CLS HOLDINGS
USA, INC.
The Gold Standard in Cannabis
Extraction and Conversion
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified
cannabis company, specializing in the extraction and
conversion of cannabinoids. CLS stands for “Cannabis Life
Sciences”, as it maintains a proprietary method of extracting
various cannabinoids from the marijuana plant and
converting them into higher quality and quantity. Several
important events have led to the opportunity of a lifetime for
Cannabis Cultivators and Industry Innovators. CLS Labs, Inc.
is poised to make significant strides in the years to come.
For the past two years, Ray Keller, a shareholder of CLS, and
a founder of CLS Labs has been developing a proprietary
method of extracting cannabinoids from cannabis plants
and converting the resulting cannabinoid extracts into
concentrates such as oils, waxes, edibles and shatter.
These concentrates may be ingested in a number of ways,
including through vaporization via electronic cigarettes and
used for a variety of pharmaceutical and other purposes.
He has also created various delivery systems and materials
to ready the converted cannabis product for different uses
by different potential distributors. Mr. Keller contributed
this intellectual property to CLS in exchange for stock in CLS.
The proprietary process is patent pending, with a patent
application having been filed.
CANNAINVESTOR Magazine